Cellular blood components and plasma-derived medicinal products (PDMPs) are obtained
from blood donated by volunteers. In a growing number of countries, in line with World …

The use of immunoglobulin (Ig) preparations (intravenous, IVIg, subcutaneous, SCIg) for
replacement and immunomodulation therapy worldwide has tripled in the past 20 years and …

Since the inception of industrial plasma fractionation during the Second World War, a
succession of protein therapies isolated from plasma have determined the volume of plasma …

Plasma from a whole blood donation (recovered plasma) or from an apheresis donation
(source plasma) is a critical substance of human origin that allows for the production of …

Canada's per capita use of intravenous immune globulin (IVIG) grew by approximately
115% between 1998 and 2006, making Canada one of the world's highest per capita users …

IVIG is essential therapy for a rapidly expanding number of debilitating and life-threatening
conditions. The evidencebased use of IVIG from an American perspective was reviewed in …

Background: Plasma-derived medicinal products (PDMPs) are medicinal products derived
from human plasma, and a number of PDMPs are listed on the WHO Model List of Essential …

Background The demand and consumption of immunoglobulins (IgGs) are growing, and
there are many difficulties in obtaining supplies. The aim of the study was to analyze the …

The two major priorities for the global community in providing patients with adequate and
safe blood components and plasma-derived medicinal products (PDMPs) are to:• Provide …

The consumption of immunoglobulins (Ig) is increasing due to better recognition of antibody
deficiencies, an aging population, and new indications. This review aims to examine the …